HLF HERBALIFE LTD.

NYSE herbalife.com


$ 8.72 $ -0.11 (-1.25 %)    

Wednesday, 15-Oct-2025 14:18:23 EDT
QQQ $ 601.53 $ -2.26 (-0.37 %)
DIA $ 462.99 $ -1.61 (-0.35 %)
SPY $ 664.40 $ -2.38 (-0.36 %)
TLT $ 90.56 $ -0.40 (-0.44 %)
GLD $ 386.22 $ 0.30 (0.08 %)
$ 8.72
$ 8.79
$ 8.71 x 100
$ 8.72 x 455
$ 8.68 - $ 8.80
$ 5.04 - $ 10.83
1,090,382
na
899.08M
$ 0.68
$ 2.77
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 04-30-2025 03-31-2025 10-Q
3 02-19-2025 12-31-2024 10-K
4 10-30-2024 09-30-2024 10-Q
5 07-31-2024 06-30-2024 10-Q
6 05-01-2024 03-31-2024 10-Q
7 02-14-2024 12-31-2023 10-K
8 11-01-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-02-2023 03-31-2023 10-Q
11 02-14-2023 12-31-2022 10-K
12 10-31-2022 09-30-2022 10-Q
13 08-02-2022 06-30-2022 10-Q
14 05-03-2022 03-31-2022 10-Q
15 02-23-2022 12-31-2021 10-K
16 11-02-2021 09-30-2021 10-Q
17 08-03-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 02-17-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 02-18-2020 12-31-2019 10-K
24 10-30-2019 09-30-2019 10-Q
25 08-01-2019 06-30-2019 10-Q
26 05-02-2019 03-31-2019 10-Q
27 02-19-2019 12-31-2018 10-K
28 10-30-2018 09-30-2018 10-Q
29 08-01-2018 06-30-2018 10-Q
30 05-03-2018 03-31-2018 10-Q
31 02-22-2018 12-31-2017 10-K
32 11-02-2017 09-30-2017 10-Q
33 08-01-2017 06-30-2017 10-Q
34 05-04-2017 03-31-2017 10-Q
35 02-23-2017 12-31-2016 10-K
36 11-01-2016 09-30-2016 10-Q
37 08-03-2016 06-30-2016 10-Q
38 05-05-2016 03-31-2016 10-Q
39 02-25-2016 12-31-2015 10-K
40 11-03-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 herbalife-sees-q3-sales-1247b-1296b-vs-1241b-est

Herbalife (NYSE:HLF) sees Q3 sales of $1.247 billion-$1.296 billion vs $1.241 billion analyst estimate.

 herbalife-raises-fy2025-sales-guidance-from-4868b-5118b-to-4943b-5143b-vs-4948b-est

Herbalife (NYSE:HLF) raises FY2025 sales outlook from $4.868 billion-$5.118 billion to $4.943 billion-$5.143 billion vs $4.948 ...

 herbalife-q2-adj-eps-059-beats-038-estimate-sales-1259b-miss-1267b-estimate

Herbalife (NYSE:HLF) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $0.38 by 56.5 ...

 herbalife-earnings-preview
Herbalife Earnings Preview
08/05/2025 18:02:22

 mizuho-maintains-neutral-on-herbalife-raises-price-target-to-9

Mizuho analyst John Baumgartner maintains Herbalife (NYSE:HLF) with a Neutral and raises the price target from $8 to $9.

 herbalife-unveils-multiburn-next-gen-multi-action-dietary-supplement-to-support-weight-loss-healthy-fat-reduction-and-energy-expenditure

New daily supplement features clinically studied botanicals to support weight loss, healthy fat reduction and energy expenditur...

 herbalifes-aloe-vera-aloin-testing-method-earns-aoac-international-certification

Certified Method Enhances Global Botanical Quality and Safety

 citigroup-maintains-buy-on-herbalife-lowers-price-target-to-11

Citigroup analyst Chasen Bender maintains Herbalife (NYSE:HLF) with a Buy and lowers the price target from $13 to $11.

 herbalife-narrows-fy2025-sales-guidance-from-484b-514b-to-487b-512b-vs-496b-est

Herbalife (NYSE:HLF) narrows FY2025 sales outlook from $4.84 billion-$5.14 billion to $4.87 billion-$5.12 billion vs $4.96 bill...

 herbalife-sees-q2-sales-1236b-1288b-vs-127b-est

Herbalife (NYSE:HLF) sees Q2 sales of $1.236 billion-$1.288 billion vs $1.27 billion analyst estimate.

 herbalife-q1-adj-eps-059-beats-037-estimate-sales-122b-miss-123b-estimate

Herbalife (NYSE:HLF) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $0.37 by 59.46...

 da-davidson-upgrades-herbalife-to-buy-raises-price-target-to-14

DA Davidson analyst Linda Bolton Weiser upgrades Herbalife (NYSE:HLF) from Neutral to Buy and raises the price target from $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION